Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applications are now open for the Wellcome Trust Infection, Immunology, and Translational Medicine DPhil programme.


This programme delivers novel, integrated graduate training in infection and immunology within a translational medicine context. It provides the opportunity for research in the basic biomedical sciences of infectious diseases, the innate and acquired immune system and the development and use of therapeutic drugs and vaccines. It consists of a one-year modular course followed by a three-year doctoral research project, which can take place in any of the participating departments at the University.

Further details of the course entry requirements, funding and costs, and how to apply, are available here.

Applicants are also strongly advised to visit the Medical Sciences Graduate School website to help them identify the most suitable course and supervisors.

The course is integrated around three themes:

  • immunology
  • infection
  • translational medicine

In the first year you will undergo three 12-week laboratory rotations and a series of training courses relevant to your work. You will be advised on your choice of courses and laboratory rotation to help tailor an individual student package.

In the second year you will initiate your DPhil project from the large number of projects available; a list of participating supervisors is available on the MSDTC website. This choice will be aided by your exposure to potential DPhil supervisors and scientific areas during the first year. Programme directors will also guide you through this process.

You will present your work from your three rotations to the management committee. Each rotation will be assessed in a different format.  The first rotation will involve an oral presentation, the second a poster presentation and the third rotation a written report. There is no formal progression mark towards the final three years; however you have to write a small grant proposal at the end of the rotation year. 

In your second year you will write a literature review on a selected topic. Many of these reviews have been published in scientific literature. You will be required to meet standard University milestones for progress and will be monitored formally via supervisor feedback forms submitted three times per year.

Similar stories

Promising discovery for treatment of neuromuscular diseases

Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.

University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.

Why we must expand newborn screening

Early diagnosis is of primary importance both to obtain the best effect of innovative medications and to accelerate their development, writes Professor Laurent Servais.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK

A preprint of ongoing work to assess effectiveness of Oxford’s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 ‘Kent’ coronavirus strain currently circulating in the UK to previously circulating variants.

Children’s pain ‘swept under the carpet for too long’ – Lancet Commission

The launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children’s pain from early years to early adulthood.